Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.36 USD | +0.15% | -2.19% | -8.73% |
04-30 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
04-30 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.73% | 1.66B | |
+32.23% | 694B | |
+29.39% | 593B | |
-1.59% | 371B | |
+19.98% | 331B | |
+7.21% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.68% | 169B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- BofA Securities Initiates Coverage on Harmony Biosciences With Neutral Rating, $35 Price Target